Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Progesterone antagonists such as CDB-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer, etc

Progesterone antagonists such as CDB-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer, etc

US Patent 8735381 · Granted May 27, 2014

Estimated economic value: $5,419,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and materials for the treatment of testosterone deficiency in men2020
Formulations and methods for vaginal delivery of antiprogenstins2020
Formulations and methods for vaginal delivery of antiprogestins2019
Formulations and methods for vaginal delivery of antiprogestins2018
Trans-clomiphene metabolites and uses thereof2018
Clomiphene synthesis using a single solvent2018
Trans-clomiphene for use in cancer therapy2017
Trans-clomiphene and its analogues as agents that increase bone mineral density2017
Compositions and methods for suppressing endometrial proliferation2017
Methods and compositions for treating progesterone-dependent conditions2017
Compositions and methods for suppressing endometrial proliferation2016
Selective estrogen receptor modulators with short half-lives and uses thereof2015